Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2013 Mar 25;131(6):1611–1623.e3. doi: 10.1016/j.jaci.2012.11.054

Table 3.

Summary of Cohorts studied

Number of patients screened Number of STAT1 mutants Number of patients with CMC Enteropathy Skin disease Endocrinopathy Autoimmune cytopenia Recurrent infections other than CMC
NIH 5 3 5/5 3/5 2/5 5/5 2/5 5/5
Seattle 35 2** 14/35 35/35 26/35 21/35 12/35 15/35
Florence 38 0 4/38 38/38 20/38 20/38 13/38 19/38
**

2 out of 3 NIH patients were also previously screened for FOXP3 mutation by the Seattle Group and they are not included in their cohort of 35.